Syndax Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 9.03 M | $119.43 M | 9.65% | 10.57% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 8.52 M | $112.63 M | 45.82% | 9.97% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 5.95 M | $78.67 M | 269.13% | 6.97% |
| VANGUARD GROUP INC | 02/11/2025 | 4.88 M | $64.54 M | -0.10% | 5.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 4.23 M | $55.98 M | -15.07% | 4.96% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 2.87 M | $37.98 M | 65.93% | 3.36% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 2.49 M | $32.94 M | 128.42% | 2.92% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 2.28 M | $30.08 M | -41.49% | 2.66% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 2.06 M | $27.29 M | 342.99% | 2.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 2.00 M | $26.44 M | 100.00% | 2.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.97 M | $26.09 M | -0.20% | 2.31% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.92 M | $25.33 M | -31.05% | 2.24% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.89 M | $25.01 M | -0.22% | 2.21% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.77 M | $23.36 M | 0.20% | 2.07% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 1.50 M | $19.83 M | -38.90% | 1.76% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 1.38 M | $18.26 M | 33.47% | 1.62% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.23 M | $16.27 M | 224.86% | 1.44% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 1.18 M | $15.57 M | 49.69% | 1.38% |
| UBS GROUP AG | 02/14/2025 | 1.03 M | $13.60 M | 602.56% | 1.20% |
| AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 1.03 M | $13.55 M | 0.00% | 1.20% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 1.02 M | $13.52 M | 29.80% | 1.20% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 988,528 | $13.07 M | 96.93% | 1.16% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 905,322 | $11.97 M | 36.19% | 1.06% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 904,000 | $11.95 M | 100.00% | 1.06% |
| JPMORGAN CHASE & CO | 02/12/2025 | 897,317 | $11.86 M | 42.96% | 1.05% |
| ALGERT GLOBAL LLC | 02/14/2025 | 785,632 | $10.39 M | 65.40% | 0.92% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 724,416 | $9.58 M | 6.03% | 0.85% |
| CRESTLINE MANAGEMENT, LP | 02/14/2025 | 713,205 | $9.43 M | 66.43% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 704,823 | $9.32 M | 1.28% | 0.83% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 680,965 | $9.00 M | 100.00% | 0.80% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 669,823 | $8.86 M | -24.44% | 0.78% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 658,627 | $8.71 M | -16.31% | 0.77% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 621,840 | $8.22 M | -23.94% | 0.73% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 620,000 | $8.20 M | 11.89% | 0.73% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 586,810 | $7.76 M | -47.60% | 0.69% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 560,532 | $7.41 M | 23.67% | 0.66% |
| CANDRIAM S.C.A. | 02/07/2025 | 547,165 | $7.23 M | -45.21% | 0.64% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 542,002 | $7.17 M | 2.90% | 0.63% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 535,952 | $7.09 M | -19.93% | 0.63% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 526,973 | $6.97 M | 3.68% | 0.62% |
| JANE STREET GROUP, LLC | 02/14/2025 | 506,000 | $6.69 M | 766.44% | 0.59% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 500,000 | $6.61 M | 0.00% | 0.59% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 475,000 | $6.28 M | 0.00% | 0.56% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 471,292 | $6.23 M | 1,309.66% | 0.55% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 441,587 | $5.84 M | -62.80% | 0.52% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 434,058 | $5.74 M | -5.54% | 0.51% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 405,193 | $5.36 M | 0.00% | 0.47% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 370,000 | $4.89 M | 100.00% | 0.43% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 364,750 | $4.82 M | 855.72% | 0.43% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 359,300 | $4.75 M | 37.29% | 0.42% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syndax Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 259 institutional investors and hedge funds held shares of Syndax Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 9.03 M
Kynam Capital Management, LP: 8.52 M
GOLDMAN SACHS GROUP INC: 5.95 M
VANGUARD GROUP INC: 4.88 M
WELLINGTON MANAGEMENT GROUP LLP: 4.23 M
StemPoint Capital LP: 2.87 M
114.75% of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 99.44 M shares in the last 24 months. This purchase volume represents approximately $1.36 B in transactions.